Journal Mobile Options
Table of Contents
Vol. 26, No. 2, 2008
Issue release date: April 2008
Dig Dis 2008;26:112–120
(DOI:10.1159/000116768)

A History of Coeliac Disease

Losowsky M.S.
Executive Chairman, Thackray Museum, Leeds, UK

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Coeliac disease may have an ancient history dating back to the 1st and 2nd centuries AD. The first clear description was given by Samuel Gee in 1888. He suggested that dietary treatment might be of benefit. In the early 20th century various diets were tried, with some success, but without clear recognition of the toxic components. The doctoral thesis of Wim Dicke of 1950 established that exclusion of wheat, rye and oats from the diet led to dramatic improvement. The toxicity was shown to be a protein component, referred to as gluten. Dicke’s colleagues, Weijers and Van de Kamer, showed that measurement of stool fat reflected the clinical condition. Early studies were in children but stool fat measurements documented that the condition could be recognised in adults. Histological abnormalities of the lining of the small intestine were demonstrated beyond doubt by Paulley in 1954 and techniques of per-oral biopsy described by Royer in 1955 and Shiner in 1956 afforded reliable diagnosis. Concurrence in monozygotic twins suggested a genetic component, confirmed by studies of HLA antigens. Additional, non-genetic factors seem likely. Circulating antibodies suggest an immunological mechanism of damage and provide non-invasive screening tests. Lymphoma, adenocarcinoma and ulceration of the small intestine and a range of immunological disorders are associated. A relationship with dermatitis herpetiformis was suggested by Samman in 1955 and established by Shuster and Marks in 1965 and 1968. The Coeliac Society (now Coeliac UK) was founded in 1968 and similar societies now exist across the world. They provide an extremely valuable service. Present problems include definition of the tolerated levels of gluten, whether oats are toxic for some or all coeliacs and the likelihood that the condition is relatively common and frequently without classical symptoms. Hope for the future is that more convenient methods of treatment will follow better understanding.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Adams F: Extant Works of Aretaeus the Cappadocian. London, The Sydenham Society, 1856.
  2. Gee SJ: The coeliac affection. St Bartholomew’s Hosp Rep 1888;24:17–20.
  3. Anderson CM: The evolution of a successful treatment of coeliac disease; in Marsh MN (ed): Coeliac Disease. London, Blackwell Scientific, 1992, p 1–16.
  4. Dawson AM, Kumar P: Coeliac disease; in Booth CC, Neale G (eds): Disorders of the Small Intestine. London, Blackwell Scientific, 1985, p 153–178.
  5. Dicke WK, Weijers HA, van de Kamer JH: Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr Stockh 1953;42:34–42.
  6. French JM, Hawkins CF, Smith N: The effect of a wheat-gluten free diet in adult idiopathic steatorrhoea – a study of 22 cases. Quart J Med 1957;26:481–499.
  7. Corazza GR, Frisoni M, Valentini R, et al: Jacomo Bartolomeo Beccari and the discovery of gluten; in Kumar PJ, Walker-Smith JA (eds): Coeliac Disease: One Hundred Years. London, St Bartholomew’s Hospital, 1988, pp 11–14.
  8. Paulley JW: Observations on the aetiology of idiopathic steatorrhoea. Br Med J 1954;2:1318–1321.
  9. Royer M, Croxatto O, et al: Biopsia duodenal por aspiración bajo control radioscópico. Prensa Med Argent 1955;42:2515–2519.
  10. Shiner M: Duodenal biopsy. Lancet 1956;1:17–19.
  11. Crosby WH, Kugler HW: Intraluminal biopsy of the small intestine: The intestinal biopsy capsule. Am J Dig Dis 1957;2:236–241.
  12. Flick AL, Quinton WE, Rubin CE: A peroral hydraulic biopsy tube for multiple sampling at any level of the gastrointestinal tract. Gastroenterology 1961;40:120–126.
  13. Losowsky MS, Walker BE, Kelleher J: Malabsorption in Clinical Practice. Oxford, Churchill Livingstone, 1974.
  14. Browning RH, Trier JS: Organ culture of mucosal biopsies in human small intestine. J Clin Invest 1969;48:1423–1432.
  15. Howdle PD, Corazza GR, et al: In vitro diagnosis of coeliac disease – an assessment. Gut 1981;22:939–947.
  16. Weinstein WM: Latent celiac sprue. Gastroenterology 1974;66:489–493.
  17. McConnell RB, Whitwell F: Small-intestinal histology in coeliac disease. Lancet 1975;2:418.
  18. Mäki M, Koskimies S, Visakorpi JK: Latent coeliac disease; in Kumar PJ, Walker-Smith JA (eds): Coeliac Disease: One Hundred Years. London, St Bartholomew’s Hospital, 1988, p 245.
  19. Ellis J: Coeliac disease and other gluten-sensitive disorders; in Buttriss J (ed): Adverse Reactions to Food. London, Blackwell Science, 2002, pp 112–130.
  20. Falchuk ZM, Rogentine GN, Strober W: Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest 1972;51:1602–1605.
  21. Stokes PL, Asquith P, et al: Histocompatibility antigens associated with adult coeliac disease. Lancet 1972;2:162–164.
  22. Brett PM, Yiannakou JY, Morris MA, et al: Common HLA alleles, rather than rare mutants, confer susceptibility to coeliac disease. Ann Hum Genet 1999;63:217–225.
  23. Partanen J: Major histocompatibility complex and coeliac disease; in Mäki M, Collin P, Visakorpi JK (eds): Coeliac Disease. Tampere, Coeliac Disease Study Group, 1997, pp 253–264.
  24. Bourgey M, Calcagno G, Tinto N, et al: HLA-related genetic risk for coeliac disease. Gut 2007;56:1054–1059.
  25. Berger E: Allergic pathogenesis of celiac disease with studies of the splitting up of pathogenic antigens by enzymes (in German). Bibl Paediatr 1958;67:1–55.
  26. Taylor KB, Thomson DL, et al: An immunological study of coeliac disease and idiopathic steatorrhoea. Br Med J 1961;2:1727–1731.
  27. Rubin W, Fauci AS, Sleisenger MN, Jeffries GH: Immunofluorescent studies in adult celiac disease. J Clin Invest 1965;44:475–485.
  28. Seah PP, Fry L, Hoffbrand AV, Holborow EJ: Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet 1971;1:834–836.
  29. Chorzelski TP, Sulej J, et al: IgA class endomysium antibodies in dermatitis herpetiformis and celiac disease. Ann NY Acad Sci 1983;420:325–334.
  30. Hälström O: Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut 1989;30:1225–1232.
  31. Hobbs JR, Hepner GW: Deficiency of gamma M-globulin in coeliac disease. Lancet 1968;1:217–220.
  32. Dieterich W, Ehnis T, et al: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797–801.
  33. Weitz JC, Montalva R, et al: Anti-transglutaminase antibodies determination for the diagnosis of celiac disease. Rev Med Childh 2003;131:31–36.
  34. Dieterich W, Eberhardt L, et al: Autoantibodies to tissue transglutiminase as predictors of celiac disease. Gastroenterology 1998;115:1317–1321.
  35. Sulkanen S, Halttunen T, et al: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998;115:1322–1328.
  36. Sollid LM, Scott H: New tool to predict celiac disease on its way to the clinics. Gastroenterology 1998;115:1584–1594.
  37. Howdle PD, Losowsky MS: Coeliac disease in adults; Marsh MN (ed): Coeliac Disease. London, Blackwell Scientific, 1992, pp 49–80.
  38. Esposito C, Paparo F, et al: Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol 2003;98:1813–1820.
  39. Shan L, Molberg Ø, et al: Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275–2279.
  40. Vader LW, de Ru A, et al: Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002;195:643–649.
  41. Reif S, Lerner A: Tissue transglutaminase – the key player in celiac disease: a review. Autoimmun Rev 2004;3:40–45.
  42. Maiuri L, Ciacci C, et al: Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology 2005;129:1400–1413.
  43. Greenberg CS, Birckbichler PJ, Rice RH: Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071–3077.
  44. Board PG, Losowsky MS, Miloszewski KJA: Factor XIII: inherited and acquired deficiency. Blood Rev 1993;7:229–242.
  45. Anwar R, Stewart AD, et al: Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995;91:728–735.
  46. Schuppan D: Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234–242.
  47. Van Heel DA, West J: Recent advances in coeliac disease. Gut 2006;55:1037–1046.
  48. Samman PD: Idiopathic steatorrhoea. Proc R Soc Med 1955;48:774–775.
  49. Shuster S, Marks J: Dermatogenic enteropathy. Lancet 1965;1:1367–1368.

    External Resources

  50. Shuster S, Watson AJ, Marks J: Coeliac syndrome in dermatitis herpetiformis. Lancet 1968;1:1101–1106.
  51. Brow JR, Parker F, et al: The small intestinal mucosa in dermatitis herpetiformis. Gastroenterology 1971;60:355–361.
  52. Reunala T, Mäki M: Dermatitis herpetiformis; a genetic disease. Eur J Dermatol 1993;3:519–526.
  53. Gull W: Fatty stools from disease of the mesenteric glands. Guy’s Hosp Rep 1855;1:369–372.
  54. Golden R: The small intestine and diarrhoea. Am J Roentgenol 1936;36:892–901.
  55. Gough KR, Read AR, Naish JM: Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut 1962;3:232–239.
  56. Harris OD, Cooke WT, et al: Malignancy in adult coeliac disease and idiopathic steatorrhoea. Am J Med 1967;42:899–912.
  57. Case Records of The Massachusetts General Hospital. N Engl J Med 1958;259:491–495.
  58. Swinson CM, Slavin G, et al: Coeliac disease and malignancy. Lancet 1983;1:111–115.
  59. Reunala TL, Leonard JN: Malignant disease in dermatitis herpetiformis. Clin Dermatol 1992;9:369–373.

    External Resources

  60. Freeman HJ, Weinstein WM, et al: Primary abdominal lymphoma. Presenting manifestations of coeliac sprue, or complicating dermatitis herpetiformis. Am J Med 1977;63:358–394.

    External Resources

  61. Holmes GKT: Coeliac disease and malignancy; in Mäki et al (eds): Coeliac Disease. Tampere, Coeliac Disease Study Group, 1997, pp 81–90.
  62. Holmes GKT, Prior P, et al: Malignancy in coeliac disease – effect of a gluten-free diet. Gut 1989;30:333–338.
  63. Lewis HM, Reunala TL, et al: Protective effect of a gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996;135:363–367.
  64. Robertson DAF, Swinson CM, et al: Coeliac disease, splenic function, and malignancy. Gut 1982;23:666–669.
  65. Thaysen ThEH: Non-tropical sprue; in Milford H (ed): A Study in Idiopathic Steatorrhoea. London, Oxford University Press, 1932.
  66. Bayless TM, Kapelowitz RF, et al: Intestinal ulceration – a complication of celiac disease. N Engl J Med 1967;276:996–1002.
  67. Scott BB: Studies in coeliac disease with particular reference to aetiology and pathogenesis; MD Thesis, University of London, 1975.
  68. Seliger G, Goldman AB, et al: Ulceration of the small intestine complicating celiac disease. Am J Dig Dis 1973;18:820–824.
  69. Neale G: A case of adult coeliac disease resistant to treatment. Br Med J 1968;2:678–684.
  70. Bayless TM, Baer A, et al: Intestinal ulceration, flat mucosa and malabsorption: report of registry of 33 patients; in McNicholl B, et al (eds): Perspectives in Coeliac Disease. Lancaster, MTP Press, 1978, pp 311–3112.
  71. Cooke WT, Holmes GKT: Coeliac Disease. Oxford, Churchill Livingstone, 1984.
  72. Collin P, Kaukinen K: Associated disorders in coeliac disease; in Lohiniemi S, Collin P, Mäki M (eds): Changing Features of Coeliac Disease. Tampere, The Finnish Coeliac Society, 1998, pp 89–91.
  73. Hansen D, Brock-Jacobsen B, et al: Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease. Diabetes Care 2006;29:2452–2456.
  74. Ventura A, Magazzu G, Greco L: Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999;117:297–303.
  75. Catassi C, Fabiani E, et al: A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 2007;85:160–166.
  76. Hischenhuber C, Crevel R, et al: Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther 2006;23:559–575.
  77. Faulkner-Hogg KB, Selby WS, Loblay RH: Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: the role of trace amounts of gluten and non-gluten food intolerances. Scand J Gastroenterol 1999;34:784–789.
  78. Ellis HJ, Parnell NDJ, Ciclitira PJ: Cornflakes and coeliac disease. Gut 1998;42(suppl 1):A35.
  79. Janatuinen EK, Pikkararainen PH, et al: A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995;333:1033–1037.
  80. Lundin KEA, Nilsen EM, et al: Oats induced villous atrophy in coeliac disease. Gut 2003;52:1649–1652.
  81. Arentz-Hansen H, Fleckenstein B, et al: Molecular basis for oat intolerance in patients with coeliac disease. PloS Med 2004;1:84–92.
  82. Haboubi NY, Taylor S, Jones S: Coeliac disease and oats: a systematic review. Postgrad Med J 2006;82:672–678.
  83. Collin P, Reunala T, Mäki M: New diagnostic strategy for coeliac disease; in Mäki M, Collin P, Visakorpi JK (eds): Coeliac Disease. Tampere, Coeliac Disease Study Group, 1997, pp 47–51.
  84. Corrao G, Corazza GR, et al: Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 1994;35:771–775.
  85. Sher KS, Mayberry JF: Female fertility, obstetric and gynaecological history in coeliac disease: a case-control study. Acta Paediatr 1996;412(suppl):76–77.

    External Resources

  86. Mazure R, Vazquez H, et al: Bone mineral affection in asymptomatic adult patients with celiac disease. Am J Gastroenterol 1994;89:2130–2134.
  87. Corazza GR, Di Sario A, et al: Bone mass and metabolism in patients with coeliac disease. Gastroenterology 1995;109:122–128.
  88. Fasano A, Berti I, et al: Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286–292.
  89. Bingley PJ, Williams AKJ, et al: Undiagnosed coeliac disease at age seven: population-based prospective birth cohort study. BMJ 2004;328:322–323.
  90. Catassi C: Screening of coeliac disease; in Mäki M, Collin P, Visakorpi JK (eds): Coeliac Disease. Tampere, Coeliac Disease Study Group, 1996, pp 23–33.
  91. Ascher H: The role of quantity and quality of gluten-containing cereals in the epidemiology of coeliac disease; in Mäki M, Collin P, Visakorpi JK (eds): Coeliac Disease. Tampere, Coeliac Disease Study Group, 1997, pp 15–22.
  92. Mäki M: Changing features of coeliac disease; in Mäki M, Collin P, Visakorpi JK (eds): Changing Features of Coeliac Disease. Tampere, The Finnish Coeliac Society, 1997, pp 1–7.
  93. Feighery C: Fortnightly review: Coeliac disease. BMJ 1999;319:236–239.
  94. Corazza GR, Andreani ML, et al: The smaller size of the ‘coeliac iceberg’ in adults. Scand J Gastroenterol 1997;32:917–919.
  95. Lack G: Immunomodulation of food allergies; in Buttriss J (ed): Adverse Reactions to Food. Oxford, Blackwell Science, 2002, pp 165–169.
  96. Roy K, Mao H-Q, et al: Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5:387–391.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50